ORAGENICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares
ORAGENICS, INC. (OGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares of 116.20 thousand shares for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-13.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares · last filed 2018-08-13
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2018-06-30 was 82.87K shares, a 55.38% increase year-over-year.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2018-03-31 was 33.33K shares, a 90.00% decline year-over-year.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2017-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- ORAGENICS, INC. share-based compensation arrangement by share-based payment award, options, vested, number of shares for the quarter ending 2017-06-30 was 53.33K shares, a 79.22% decline year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares 9 month |
|---|---|---|---|
| 2018-06-30 | 82.87K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | 116.20K shares 10-Q · filed 2018-08-13 | |
| 2018-03-31 | 33.33K shares 10-Q · filed 2018-05-15 | ||
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | 53.33K shares derived: sum of 2 quarters · filed 2017-10-31 | 386.67K shares 10-Q · filed 2017-10-31 |
| 2017-06-30 | 53.33K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 386.67K shares 10-Q · filed 2017-08-14 | |
| 2017-03-31 | 333.33K shares 10-Q · filed 2017-05-15 | ||
| 2016-09-30 | 302.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 559.16K shares derived: sum of 2 quarters · filed 2016-11-14 | 559.16K shares 10-Q · filed 2016-11-14 |
| 2016-06-30 | 256.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | 256.67K shares 10-Q · filed 2016-08-15 | |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-16 | ||
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 21.67K shares derived: sum of 2 quarters · filed 2015-11-06 | 28.33K shares 10-Q · filed 2015-11-06 |
| 2015-06-30 | 21.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | 28.33K shares 10-Q · filed 2015-08-07 | |
| 2015-03-31 | 6.67K shares 10-Q · filed 2015-05-08 | ||
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | 57.39K shares derived: sum of 2 quarters · filed 2014-11-03 | 67.39K shares 10-Q · filed 2014-11-03 |
| 2014-06-30 | 57.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | 67.39K shares 10-Q · filed 2014-08-07 | |
| 2014-03-31 | 10.00K shares 10-Q · filed 2014-05-09 | ||
| 2013-09-30 | 42.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | 50.53K shares 10-Q · filed 2013-10-25 | |
| 2013-06-30 | 8.33K shares 10-Q · filed 2013-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |